>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
:
  • URBN -5%, (discloses thus far during the Q1, comparable retail segment net sales are mid single-digit negative; also downgraded to Neutral from Buy at Citigroup)
  • EDAP -3.7%
M&A news:
  • KATE -12.3% (Kate Spade lower on reports of sales process being extended as negotiations continue)
Select EU financial related names showing weakness:
  • DB -3.2%, BCS -2.4%, RBS -2.3%, ING -1.7%, BBVA -1.7%, SAN-1.7%, CS -1.1%, PUK -1%
Other news:
  • SDRL -35.3% (extends a series of key dates as part of the Co's ongoing restructuring efforts; expects schemes of arrangement or chapter 11 proceedings)
  • SDLP -12.3% (in sympathy with SDRL)
  • DGLY -4.7% (files for 800K share common stock offering by stockholders issuable upon the exercise of Common Stock Purchase Warrants )
  • NVCR -4.5% (following ~40% move higher on Monday)
  • PIR -4.1% (appoints Alasdair James as President and CEO effective start date of May 1, 2017)
  • NMFC -3% (commences underwritten offering of 5 mln shares of common stock; provides preliminary estimate of net asset value per share as of March 31)
  • ALV -2.4% (following yesterday's downbeat March US auto sales' releases)
  • PN -1.5% (light volume; to delay the filing of its Annual Report on Form 10-K for the year ended December 31, 2016; audit committee commences internal review regarding certain accounting matters)
  • PLUG -1.5% (enters into an At Market Issuance Sales Agreement)
  • NADL -1.2% (in sympathy with SDRL)
  • PRGO -1.1% (in sympathy with peer TEVA)
  • GSK -0.9% (files debt securities shelf offering for up to $10 bln)
Analyst comments:
  • NVDA -2.7% (downgraded to Underweight from Sector Weight at Pacific Crest)
  • LB -2% (downgraded to Neutral from Buy at Citigroup )
  • BAC -1.7% (downgraded to Neutral from Buy at Citigroup)
  • GOOGL -0.8% (downgraded to Market Perform from Outperform at BMO Capital)
  • IBM -0.5% (initiated with a Sell at Berenberg; tgt $140)